Stimulation of cAMP production and cyclooxygenase-2 by prostaglandin E(2) and selective prostaglandin receptor agonists in murine osteoblastic cells.

Prostaglandins (PGs), particularly PGE(2), can stimulate bone resorption and formation and auto-amplify their effects by inducing cyclooxygenase (COX)-2. We examined the role of different PG receptors in stimulating cAMP production and COX-2 expression in murine calvarial osteoblasts. Cells were obtained from PGE(2) receptor (EP2R and EP4R) wild-type and knockout (KO) mice and from mice transgenic for the COX-2 promoter fused to a luciferase reporter. We analyzed effects of selective agonists, EP2A and EP4A, for EP2R and EP4R, which mediate the increase in cAMP in response to PGE(2). We also tested agonists for other PGE(2) receptors (EP1A and EP3A) and for prostacyclin (IPA), prostaglandin D(2) (DPA), thromboxane (TPA), and prostaglandin F(2alpha) (FPA) receptors. PGE(2) and EP2A were the most effective stimulators of cAMP production. EP4A, IPA, and DPA produced smaller responses, and EP1A, EP3A, FPA, and TPA were ineffective. In EP2R KO cells, cAMP responses to PGE(2) were reduced by 80%, and responses to EP2A were abrogated. In EP4R KO cells, cAMP responses to PGE(2) and EP2A showed a small reduction, while the response to EP4A was abrogated. Pretreatment with PGE(2), EP2A, or EP4A down-regulated the subsequent response to the respective ligands. COX-2 induction was measured by increased luciferase activity and mRNA expression. PGE(2) was the most effective agonist; EP2A and another selective EP2R agonist, butaprost, showed similar efficacy, and EP4A was less effective. EP2A and EP4A effects on luciferase activity were additive, and effects of the combination were similar to PGE(2) itself. IPA, TPA, and DPA produced 2- to 6-fold increases in COX-2 expression. FPA was a weak agonist, while EP1A and EP3A were inactive. Treatment with specific inhibitors indicated that PGE(2), EP2A, and EP4A induced COX-2 expression largely through protein kinase A (PKA). We conclude that the PG induction of COX-2 in this system generally paralleled effects on cAMP production and was mediated predominantly via the PKA pathway.

[1]  B. Ashby,et al.  Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: role of the carboxyl terminus in EP4 receptor sequestration. , 2000, Molecular pharmacology.

[2]  S. Narumiya,et al.  Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity , 1993, Nature.

[3]  R. Breyer,et al.  Prostaglandin receptor EP2 mediates PGE2 stimulated hypercalcemia in mice in vivo. , 2002, Prostaglandins & other lipid mediators.

[4]  K. Ohya,et al.  Expression of prostaglandin E receptor subtypes in bone: expression of EP2 in bone development. , 1995, Bone.

[5]  R. Young,et al.  Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro. , 2002, Bone.

[6]  L. Raisz,et al.  Autoregulation of inducible prostaglandin G/H synthase in osteoblastic cells by prostaglandins , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  H. S. Kim,et al.  Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor. , 1999, The Journal of clinical investigation.

[8]  G. FitzGerald,et al.  Genetic and pharmacological analysis of prostanoid receptor function. , 2001, The Journal of clinical investigation.

[9]  S. Ito,et al.  Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. , 1993, The Journal of biological chemistry.

[10]  S. Narumiya,et al.  The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. , 2000, Endocrinology.

[11]  B. Ashby,et al.  Agonist‐induced internalization and mitogen‐activated protein kinase activation of the human prostaglandin EP4 receptor , 2001, FEBS letters.

[12]  G. Rodan,et al.  Expression of the prostaglandin E2 (PGE2) receptor subtype EP4 and its regulation by PGE2 in osteoblastic cell lines and adult rat bone tissue1 , 2001 .

[13]  S. Narumiya,et al.  Prostaglandin E2 (PGE2) Autoamplifies its Production Through EP1 Subtype of PGE Receptor in Mouse Osteoblastic MC3T3-E1 Cells , 1998, Calcified Tissue International.

[14]  B. Koller,et al.  The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth , 1997, Nature.

[15]  S. Narumiya,et al.  Cloning and expression of a cDNA for rat prostacyclin receptor. , 1994, Biochimica et biophysica acta.

[16]  K. Nakao,et al.  Crucial Involvement of the EP4 Subtype of Prostaglandin E Receptor in Osteoclast Formation by Proinflammatory Cytokines and Lipopolysaccharide , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  Mark A. Magnuson,et al.  Salt–sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor , 1999, Nature Medicine.

[18]  H. Kawaguchi,et al.  The role of prostaglandins in the regulation of bone metabolism. , 1995, Clinical orthopaedics and related research.

[19]  John P. Bilezikian,et al.  Principles of Bone Biology , 1996 .

[20]  E H Burger,et al.  Pulsating Fluid Flow Stimulates Prostaglandin Release and Inducible Prostaglandin G/H Synthase mRNA Expression in Primary Mouse Bone Cells , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  R. Haché,et al.  Characterization of the prostaglandin receptors in human osteoblasts in culture. , 2001, Prostaglandins, leukotrienes, and essential fatty acids.

[22]  J. Drazen,et al.  Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature. , 1995, Advances in prostaglandin, thromboxane, and leukotriene research.

[23]  S. Morham,et al.  Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. , 2000, The Journal of clinical investigation.

[24]  S. Narumiya,et al.  Prostaglandin E receptor subtypes in mouse osteoblastic cell line. , 1996, Endocrinology.